ACE2 gene combined with exercise training attenuates central AngII/AT1 axis function and oxidative stress in a prehypertensive rat model
Angiotensin-converting enzyme 2 (ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII...
Saved in:
Published in | Journal of applied physiology (1985) Vol. 132; no. 6; pp. 1460 - 1467 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Physiological Society
01.06.2022
|
Series | Physical Activity and the Brain |
Subjects | |
Online Access | Get full text |
ISSN | 8750-7587 1522-1601 1522-1601 |
DOI | 10.1152/japplphysiol.00459.2021 |
Cover
Loading…
Abstract | Angiotensin-converting enzyme 2 (ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats.
Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study, lentivirus containing enhanced green fluorescent protein (eGFP) and ACE2 were microinjected into the paraventricular nucleus (PVN) of young male spontaneous hypertensive rats (SHRs), and SHRs were assigned into five groups: sedentary (SHR), SHR-ExT, SHR-eGFP, ACE2 gene (SHR-ACE2), and ACE2 gene combined with ExT (SHR-ACE2-ExT). Wistar–Kyoto (WKY) rats were used as a control. ACE2 gene or ExT significantly delayed the elevation of blood pressure, and the combined effect prevented the development and progression of prehypertension. Either ACE2 overexpression or ExT improved arterial baroreflex sensitivity (BRS), whereas the combined effect normalized BRS in SHR. Compared with SHR, SHR-ACE2 and SHR-ExT displayed a significantly higher level of ACE2 protein but had lower plasma norepinephrine (NE) and angiotensin II (AngII) as well as angiotensin II type 1 receptor (AT1) protein expression in the PVN. SHR-ACE2-ExT showed the largest decrease in AngII and AT1 protein expression. Reactive oxygen species (ROS) level and NADPH oxidase (NOX2 and NOX4) protein expression in PVN were also decreased in SHR-ACE2-ExT group than in SHR-ACE2 and SHR-ExT groups. It was concluded that the combined effect has effectively prevented prehypertension progression and baroreflex dysfunction in SHR, which is associated with the reduction in AngII/AT1 axis function and oxidative stress in the PVN.
NEW & NOTEWORTHY Angiotensin-converting enzyme 2 ( ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats. |
---|---|
AbstractList | Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study, lentivirus containing enhanced green fluorescent protein (eGFP) and
were microinjected into the paraventricular nucleus (PVN) of young male spontaneous hypertensive rats (SHRs), and SHRs were assigned into five groups: sedentary (SHR), SHR-ExT, SHR-eGFP,
gene (SHR-ACE2), and
gene combined with ExT (SHR-ACE2-ExT). Wistar-Kyoto (WKY) rats were used as a control.
gene or ExT significantly delayed the elevation of blood pressure, and the combined effect prevented the development and progression of prehypertension. Either
overexpression or ExT improved arterial baroreflex sensitivity (BRS), whereas the combined effect normalized BRS in SHR. Compared with SHR, SHR-ACE2 and SHR-ExT displayed a significantly higher level of ACE2 protein but had lower plasma norepinephrine (NE) and angiotensin II (AngII) as well as angiotensin II type 1 receptor (AT1) protein expression in the PVN. SHR-ACE2-ExT showed the largest decrease in AngII and AT1 protein expression. Reactive oxygen species (ROS) level and NADPH oxidase (NOX2 and NOX4) protein expression in PVN were also decreased in SHR-ACE2-ExT group than in SHR-ACE2 and SHR-ExT groups. It was concluded that the combined effect has effectively prevented prehypertension progression and baroreflex dysfunction in SHR, which is associated with the reduction in AngII/AT1 axis function and oxidative stress in the PVN.
Angiotensin-converting enzyme 2 (
) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats. Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study, lentivirus containing enhanced green fluorescent protein (eGFP) and ACE2 were microinjected into the paraventricular nucleus (PVN) of young male spontaneous hypertensive rats (SHRs), and SHRs were assigned into five groups: sedentary (SHR), SHR-ExT, SHR-eGFP, ACE2 gene (SHR-ACE2), and ACE2 gene combined with ExT (SHR-ACE2-ExT). Wistar-Kyoto (WKY) rats were used as a control. ACE2 gene or ExT significantly delayed the elevation of blood pressure, and the combined effect prevented the development and progression of prehypertension. Either ACE2 overexpression or ExT improved arterial baroreflex sensitivity (BRS), whereas the combined effect normalized BRS in SHR. Compared with SHR, SHR-ACE2 and SHR-ExT displayed a significantly higher level of ACE2 protein but had lower plasma norepinephrine (NE) and angiotensin II (AngII) as well as angiotensin II type 1 receptor (AT1) protein expression in the PVN. SHR-ACE2-ExT showed the largest decrease in AngII and AT1 protein expression. Reactive oxygen species (ROS) level and NADPH oxidase (NOX2 and NOX4) protein expression in PVN were also decreased in SHR-ACE2-ExT group than in SHR-ACE2 and SHR-ExT groups. It was concluded that the combined effect has effectively prevented prehypertension progression and baroreflex dysfunction in SHR, which is associated with the reduction in AngII/AT1 axis function and oxidative stress in the PVN.NEW & NOTEWORTHY Angiotensin-converting enzyme 2 (ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats.Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study, lentivirus containing enhanced green fluorescent protein (eGFP) and ACE2 were microinjected into the paraventricular nucleus (PVN) of young male spontaneous hypertensive rats (SHRs), and SHRs were assigned into five groups: sedentary (SHR), SHR-ExT, SHR-eGFP, ACE2 gene (SHR-ACE2), and ACE2 gene combined with ExT (SHR-ACE2-ExT). Wistar-Kyoto (WKY) rats were used as a control. ACE2 gene or ExT significantly delayed the elevation of blood pressure, and the combined effect prevented the development and progression of prehypertension. Either ACE2 overexpression or ExT improved arterial baroreflex sensitivity (BRS), whereas the combined effect normalized BRS in SHR. Compared with SHR, SHR-ACE2 and SHR-ExT displayed a significantly higher level of ACE2 protein but had lower plasma norepinephrine (NE) and angiotensin II (AngII) as well as angiotensin II type 1 receptor (AT1) protein expression in the PVN. SHR-ACE2-ExT showed the largest decrease in AngII and AT1 protein expression. Reactive oxygen species (ROS) level and NADPH oxidase (NOX2 and NOX4) protein expression in PVN were also decreased in SHR-ACE2-ExT group than in SHR-ACE2 and SHR-ExT groups. It was concluded that the combined effect has effectively prevented prehypertension progression and baroreflex dysfunction in SHR, which is associated with the reduction in AngII/AT1 axis function and oxidative stress in the PVN.NEW & NOTEWORTHY Angiotensin-converting enzyme 2 (ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats. Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study, lentivirus containing enhanced green fluorescent protein (eGFP) and ACE2 were microinjected into the paraventricular nucleus (PVN) of young male spontaneous hypertensive rats (SHRs), and SHRs were assigned into five groups: sedentary (SHR), SHR-ExT, SHR-eGFP, ACE2 gene (SHR-ACE2), and ACE2 gene combined with ExT (SHR-ACE2-ExT). Wistar–Kyoto (WKY) rats were used as a control. ACE2 gene or ExT significantly delayed the elevation of blood pressure, and the combined effect prevented the development and progression of prehypertension. Either ACE2 overexpression or ExT improved arterial baroreflex sensitivity (BRS), whereas the combined effect normalized BRS in SHR. Compared with SHR, SHR-ACE2 and SHR-ExT displayed a significantly higher level of ACE2 protein but had lower plasma norepinephrine (NE) and angiotensin II (AngII) as well as angiotensin II type 1 receptor (AT1) protein expression in the PVN. SHR-ACE2-ExT showed the largest decrease in AngII and AT1 protein expression. Reactive oxygen species (ROS) level and NADPH oxidase (NOX2 and NOX4) protein expression in PVN were also decreased in SHR-ACE2-ExT group than in SHR-ACE2 and SHR-ExT groups. It was concluded that the combined effect has effectively prevented prehypertension progression and baroreflex dysfunction in SHR, which is associated with the reduction in AngII/AT1 axis function and oxidative stress in the PVN. NEW & NOTEWORTHY Angiotensin-converting enzyme 2 ( ACE2 ) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats. Angiotensin-converting enzyme 2 (ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats. Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study, lentivirus containing enhanced green fluorescent protein (eGFP) and ACE2 were microinjected into the paraventricular nucleus (PVN) of young male spontaneous hypertensive rats (SHRs), and SHRs were assigned into five groups: sedentary (SHR), SHR-ExT, SHR-eGFP, ACE2 gene (SHR-ACE2), and ACE2 gene combined with ExT (SHR-ACE2-ExT). Wistar–Kyoto (WKY) rats were used as a control. ACE2 gene or ExT significantly delayed the elevation of blood pressure, and the combined effect prevented the development and progression of prehypertension. Either ACE2 overexpression or ExT improved arterial baroreflex sensitivity (BRS), whereas the combined effect normalized BRS in SHR. Compared with SHR, SHR-ACE2 and SHR-ExT displayed a significantly higher level of ACE2 protein but had lower plasma norepinephrine (NE) and angiotensin II (AngII) as well as angiotensin II type 1 receptor (AT1) protein expression in the PVN. SHR-ACE2-ExT showed the largest decrease in AngII and AT1 protein expression. Reactive oxygen species (ROS) level and NADPH oxidase (NOX2 and NOX4) protein expression in PVN were also decreased in SHR-ACE2-ExT group than in SHR-ACE2 and SHR-ExT groups. It was concluded that the combined effect has effectively prevented prehypertension progression and baroreflex dysfunction in SHR, which is associated with the reduction in AngII/AT1 axis function and oxidative stress in the PVN. NEW & NOTEWORTHY Angiotensin-converting enzyme 2 ( ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats. Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study, lentivirus containing enhanced green fluorescent protein (eGFP) and ACE2 were microinjected into the paraventricular nucleus (PVN) of young male spontaneous hypertensive rats (SHRs), and SHRs were assigned into five groups: sedentary (SHR), SHR-ExT, SHR-eGFP, ACE2 gene (SHR-ACE2), and ACE2 gene combined with ExT (SHR-ACE2-ExT). Wistar–Kyoto (WKY) rats were used as a control. ACE2 gene or ExT significantly delayed the elevation of blood pressure, and the combined effect prevented the development and progression of prehypertension. Either ACE2 overexpression or ExT improved arterial baroreflex sensitivity (BRS), whereas the combined effect normalized BRS in SHR. Compared with SHR, SHR-ACE2 and SHR-ExT displayed a significantly higher level of ACE2 protein but had lower plasma norepinephrine (NE) and angiotensin II (AngII) as well as angiotensin II type 1 receptor (AT1) protein expression in the PVN. SHR-ACE2-ExT showed the largest decrease in AngII and AT1 protein expression. Reactive oxygen species (ROS) level and NADPH oxidase (NOX2 and NOX4) protein expression in PVN were also decreased in SHR-ACE2-ExT group than in SHR-ACE2 and SHR-ExT groups. It was concluded that the combined effect has effectively prevented prehypertension progression and baroreflex dysfunction in SHR, which is associated with the reduction in AngII/AT1 axis function and oxidative stress in the PVN. |
Author | Liu, Guo-Ying Chen, Xiu-Yun Pei, Chun Xu, Gui-Qing Lin, Cheng Gao, Lie Wang, Shi-Zhong Pan, Yan-Xia |
Author_xml | – sequence: 1 givenname: Xiu-Yun orcidid: 0000-0002-1025-2290 surname: Chen fullname: Chen, Xiu-Yun organization: Department of Rehabilitation Medicine, Health School of Fujian Medical University, Fuzhou, China – sequence: 2 givenname: Cheng surname: Lin fullname: Lin, Cheng organization: Department of Rehabilitation Medicine, Health School of Fujian Medical University, Fuzhou, China – sequence: 3 givenname: Guo-Ying surname: Liu fullname: Liu, Guo-Ying organization: Department of Rehabilitation Medicine, Health School of Fujian Medical University, Fuzhou, China – sequence: 4 givenname: Chun surname: Pei fullname: Pei, Chun organization: Department of Rehabilitation Medicine, Health School of Fujian Medical University, Fuzhou, China – sequence: 5 givenname: Gui-Qing surname: Xu fullname: Xu, Gui-Qing organization: Department of Rehabilitation Medicine, Health School of Fujian Medical University, Fuzhou, China – sequence: 6 givenname: Lie surname: Gao fullname: Gao, Lie organization: Department of Cellular and Integrative, Physiology of University of Nebraska Medical Center, Omaha, Nebraska – sequence: 7 givenname: Shi-Zhong surname: Wang fullname: Wang, Shi-Zhong organization: Department of Rehabilitation Medicine, Health School of Fujian Medical University, Fuzhou, China – sequence: 8 givenname: Yan-Xia orcidid: 0000-0002-0570-4117 surname: Pan fullname: Pan, Yan-Xia organization: Department of Rehabilitation Medicine, Health School of Fujian Medical University, Fuzhou, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35546127$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUsFuEzEQtVARTQu_AJa4cNnU9nrt3QNCUVQgUiUuuVte7yRxtLEX29smf8Bn46WhKr1wsjzvzZs3mneFLpx3gNAHSuaUVuxmr4ehH3anaH0_J4RXzZwRRl-hWUZZQQWhF2hWy4oUsqrlJbqKcU8I5byib9BlWVVcUCZn6NdiecvwFhxg4w-tddDhB5t2GI4QjI2AU9DWWbfFOiVwo04QsQGXyz1euO1qdbNYU6yPNuLN6Eyy3mHtOuyPttPJ3gOOKUCM2OY6HgLsTgOELBUnLOiED76D_i16vdF9hHfn9xqtv96ul9-Lux_fVsvFXWE4F6noOk5pw0F3NZQcGkFFIwxjQlYtASnzj0lO2EaWujWacEbaUvNWyFp2JSmv0ZdH2WFsD9CdF1FDsAcdTsprq_5FnN2prb9XeSqtOZdZ4dNZIfifI8SkDjYa6HvtwI9RMSG4bHjDaaZ-fEHd-zG4vJ6aDGevNSkz6_1zS09e_h4pE-QjwQQfY4DNE4USNcVBPY-D-hMHNcUhd35-0Wls0tOJpqv2_-3_DRAJwsg |
CitedBy_id | crossref_primary_10_1152_japplphysiol_00736_2022 crossref_primary_10_1038_s41440_023_01480_y crossref_primary_10_3390_ijms26062822 |
Cites_doi | 10.1371/journal.pone.0022682 10.1371/journal.pone.0094927 10.3389/fnins.2018.00493 10.1161/01.HYP.0000256955.74461.93 10.1161/HYPERTENSIONAHA.110.164244 10.1093/eurheartj/ehaa605 10.1152/ajpheart.00349.2015 10.1016/j.autneu.2017.09.012 10.1152/ajpregu.00222.2010 10.1139/apnm-2014-0351 10.1161/01.HYP.0000259942.38108.20 10.1161/HYPERTENSIONAHA.115.03624 10.1002/phy2.264 10.1007/s12264-018-0316-5 10.1161/CIRCRESAHA.109.208645 10.1161/HYPERTENSIONAHA.117.09600 10.1093/cvr/cvr242 10.1161/CIRCULATIONAHA.110.955369 10.1113/expphysiol.2008.046128 10.1161/HYPERTENSIONAHA.111.176636 10.1152/ajpheart.00330.2011 10.1016/j.brainres.2019.02.004 10.1113/expphysiol.2012.067165 10.1097/MNH.0b013e328341164a 10.1152/ajpregu.00366.2014 10.1249/MSS.0000000000002263 10.1590/1414-431X20165349 10.1155/2016/7413963 10.1097/HJH.0b013e328305e1a5 10.3109/10641963.2012.681084 10.1161/HYPERTENSIONAHA.106.085548 10.1161/STROKEAHA.112.667063 |
ContentType | Journal Article |
Copyright | Copyright American Physiological Society Jun 2022 Copyright © 2022 the American Physiological Society. 2022 American Physiological Society |
Copyright_xml | – notice: Copyright American Physiological Society Jun 2022 – notice: Copyright © 2022 the American Physiological Society. 2022 American Physiological Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7TK 7TS 7U7 8FD C1K FR3 P64 7X8 5PM |
DOI | 10.1152/japplphysiol.00459.2021 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts Physical Education Index Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database Toxicology Abstracts Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Physical Education Index Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef Technology Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
DocumentTitleAlternate | BENEFITS OF ACE2 COMBINED WITH ExT IN PREHYPERTENSION |
EISSN | 1522-1601 |
EndPage | 1467 |
ExternalDocumentID | PMC11918447 35546127 10_1152_japplphysiol_00459_2021 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Youth Found of Fujian Medical University grantid: 2014MP025 – fundername: NHLBI NIH HHS grantid: R01 HL160820 – fundername: National Natural Science Foundation of China (NSFC) grantid: 81372111 |
GroupedDBID | --- -~X .55 18M 29J 2WC 4.4 53G 5VS 85S AAFWJ AAYXX ABCQX ABDNZ ABHWK ABJNI ABKWE ABOCM ACBEA ACGFO ACGFS ACIWK ACPRK ADBBV ADFNX AEILP AENEX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BKKCC BTFSW CITATION CS3 DIK DU5 E3Z EBS EJD EMOBN F5P FRP GX1 H13 H~9 ITBOX KQ8 L7B OK1 P2P P6G PQQKQ RAP RHI RPL RPRKH SJN TR2 UHB UKR UPT W8F WH7 WOQ X7M XSW YBH YQT YWH ~02 CGR CUY CVF ECM EIF NPM 7QP 7QR 7TK 7TS 7U7 8FD C1K FR3 P64 7X8 5PM |
ID | FETCH-LOGICAL-c446t-dd41194ead8e34e961696c22675b0e7769627402f73abca0420b3a4b6787d303 |
ISSN | 8750-7587 1522-1601 |
IngestDate | Thu Aug 21 18:39:21 EDT 2025 Fri Sep 05 09:35:33 EDT 2025 Mon Jun 30 10:38:16 EDT 2025 Fri Mar 21 01:26:05 EDT 2025 Tue Jul 01 03:17:03 EDT 2025 Thu Apr 24 23:01:18 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | baroreflex hypertension renin-angiotensin system exercise training paraventricular nucleus |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c446t-dd41194ead8e34e961696c22675b0e7769627402f73abca0420b3a4b6787d303 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 X.-Y. Chen and C. Lin contributed equally to this work. |
ORCID | 0000-0002-1025-2290 0000-0002-0570-4117 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/11918447 |
PMID | 35546127 |
PQID | 2675696803 |
PQPubID | 40905 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11918447 proquest_miscellaneous_2664794941 proquest_journals_2675696803 pubmed_primary_35546127 crossref_primary_10_1152_japplphysiol_00459_2021 crossref_citationtrail_10_1152_japplphysiol_00459_2021 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-06-01 |
PublicationDateYYYYMMDD | 2022-06-01 |
PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Bethesda – name: Rockville, MD |
PublicationSeriesTitle | Physical Activity and the Brain |
PublicationTitle | Journal of applied physiology (1985) |
PublicationTitleAlternate | J Appl Physiol (1985) |
PublicationYear | 2022 |
Publisher | American Physiological Society |
Publisher_xml | – name: American Physiological Society |
References | B20 B23 B24 B25 B27 B28 B29 Zhao XL (B8) 2018; 34 Pan YX (B22) 2014; 23 B30 B31 B10 B32 B11 B33 B12 B34 B13 B35 B14 Paxinos G (B21) 2005 B36 B15 B16 B38 B17 B18 Peng WW (B37) 2019; 35 B19 B2 B3 B4 B5 B6 B7 B9 Liu GY (B26) 2021; 37 Ghadieh AS (B1) 2015; 61 |
References_xml | – ident: B35 doi: 10.1371/journal.pone.0022682 – ident: B5 doi: 10.1371/journal.pone.0094927 – ident: B29 doi: 10.3389/fnins.2018.00493 – volume: 37 start-page: 218 year: 2021 ident: B26 publication-title: Chin J Pathophysiol – ident: B33 doi: 10.1161/01.HYP.0000256955.74461.93 – ident: B34 doi: 10.1161/HYPERTENSIONAHA.110.164244 – volume: 23 start-page: 364 year: 2014 ident: B22 publication-title: Chin J Cardiovasc Rehab Med – ident: B2 doi: 10.1093/eurheartj/ehaa605 – ident: B27 doi: 10.1152/ajpheart.00349.2015 – ident: B28 doi: 10.1016/j.autneu.2017.09.012 – ident: B10 doi: 10.1152/ajpregu.00222.2010 – ident: B4 doi: 10.1139/apnm-2014-0351 – ident: B11 doi: 10.1161/01.HYP.0000259942.38108.20 – ident: B15 doi: 10.1161/HYPERTENSIONAHA.115.03624 – ident: B36 doi: 10.1002/phy2.264 – ident: B9 doi: 10.1007/s12264-018-0316-5 – ident: B14 doi: 10.1161/CIRCRESAHA.109.208645 – ident: B18 doi: 10.1161/HYPERTENSIONAHA.117.09600 – ident: B19 doi: 10.1093/cvr/cvr242 – ident: B20 doi: 10.1161/CIRCULATIONAHA.110.955369 – ident: B6 doi: 10.1113/expphysiol.2008.046128 – ident: B31 doi: 10.1161/HYPERTENSIONAHA.111.176636 – ident: B32 doi: 10.1152/ajpheart.00330.2011 – ident: B38 doi: 10.1016/j.brainres.2019.02.004 – ident: B16 doi: 10.1113/expphysiol.2012.067165 – ident: B12 doi: 10.1097/MNH.0b013e328341164a – ident: B13 doi: 10.1152/ajpregu.00366.2014 – volume: 35 start-page: 1081 year: 2019 ident: B37 publication-title: Chin J Pathophysiol – ident: B23 doi: 10.1249/MSS.0000000000002263 – ident: B24 doi: 10.1590/1414-431X20165349 – ident: B25 doi: 10.1155/2016/7413963 – volume: 61 start-page: 233 year: 2015 ident: B1 publication-title: Can Fam Physician – ident: B7 doi: 10.1097/HJH.0b013e328305e1a5 – ident: B30 doi: 10.3109/10641963.2012.681084 – volume: 34 start-page: 35 year: 2018 ident: B8 publication-title: Chin J Pathophysiol – volume-title: The Rat Brain in Stereotaxic Coordinates year: 2005 ident: B21 – ident: B3 doi: 10.1161/HYPERTENSIONAHA.106.085548 – ident: B17 doi: 10.1161/STROKEAHA.112.667063 |
SSID | ssj0014451 |
Score | 2.4050353 |
Snippet | Angiotensin-converting enzyme 2 (ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted... Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study,... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1460 |
SubjectTerms | ACE2 ACE2 gene Angiotensin Angiotensin I - metabolism Angiotensin II Angiotensin II - metabolism Angiotensin-converting enzyme 2 Angiotensin-Converting Enzyme 2 - metabolism Animal models Animals Baroreceptors Blood Pressure CYBB protein Fitness training programs Fluorescence Green fluorescent protein Hypertension Hypertension - metabolism Hypertension - therapy Male NAD(P)H oxidase Norepinephrine NOX4 protein Oxidative stress Oxidative Stress - physiology Paraventricular Hypothalamic Nucleus Paraventricular nucleus Peptidyl-dipeptidase A Physical Conditioning, Animal - physiology Physical training Prehypertension - metabolism Pressure effects Protein expression Proteins Rats Rats, Inbred SHR Rats, Inbred WKY Reactive oxygen species Reflexes |
Title | ACE2 gene combined with exercise training attenuates central AngII/AT1 axis function and oxidative stress in a prehypertensive rat model |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35546127 https://www.proquest.com/docview/2675696803 https://www.proquest.com/docview/2664794941 https://pubmed.ncbi.nlm.nih.gov/PMC11918447 |
Volume | 132 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIiEuCFoegYIWCXGJ3PqxXsfHKEppUVs4uFJ6smzvprVEbdTaUssv4Ffx25jZh52EltfFStb2er3zZXZmM_MNIe8EF8KXbOEU8UI4LCs8Z6xyZfI4yEIfIKMoNo6O-f4J-zgP54PBj6WopbbJd4pvt-aV_I9UoQ3kilmy_yDZrlNogM8gXziChOH4VzKeTGc-1kDGiPMLcHFtKLmto9QVgBghi2bVol05MuGYo0l1dnCAdAqJN8quy6sRLnGNjU6ur0uhOcFNNkkJ7cgocA6O66UNewf46Fo6d9i4mbFx1f6JZntCYqh4HC7tQExNgsi8bJ3Ttg8RKk08gDSLq2pr1UZ-WzunZd_8WZb6UnO32cUAB7iLtlpKHEC1b8ejIGoiV3udCN6V64CLo9doaXQ2dOdx05tV6v2u6ZqKhqXBvX3tCH1VswBmxszKDhq8mM2kk7hX2bqPP6V7J4eHaTKbJ_fIfT-KVJjAh3kXYuQh-ZveX9aDNvGF8KDdOx6zah394vKsR-4umULJY_LIyJdONCCfkIGsNsnWpMqa-uKGvqfd7N5skgdHJnhji3xHuFKEK7VwpQhXauFKLVxpD1dqxkAVXHcBrBTBSi1YKYCVdmClGqy0hHa6BlYKYKUKrE9JsjdLpvuOKQTiFIzxxhGCeV7MQOmNZcBkzD0e8wIchyjMXRlFXFWQcv1FFGR5kcE65OZBxnIwxCIBNtozslHVlXxBaBwIV-Q8X-QiYhms1kEBfcV-FuFXKYeE2_lPC0OSj-_-JVXOcuiny4JLleBSFNyQuN2NXzVPzJ9v2bYCTo1SuUrxnZCvyg2G5G13GlQ-_o-XVbJu8RqOdSFiBl0813jononuAzgt0ZCMV5DSXYB08qtnqvJc0coj1eOYsejl78f1ijzsf8DbZKO5bOVrMMyb_I1C_0_rMOtN |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ACE2+gene+combined+with+exercise+training+attenuates+central+AngII%2FAT1+axis+function+and+oxidative+stress+in+a+prehypertensive+rat+model&rft.jtitle=Journal+of+applied+physiology+%281985%29&rft.au=Chen%2C+Xiu-Yun&rft.au=Lin%2C+Cheng&rft.au=Liu%2C+Guo-Ying&rft.au=Pei%2C+Chun&rft.date=2022-06-01&rft.pub=American+Physiological+Society&rft.issn=8750-7587&rft.eissn=1522-1601&rft.volume=132&rft.issue=6&rft.spage=1460&rft_id=info:doi/10.1152%2Fjapplphysiol.00459.2021&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=8750-7587&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=8750-7587&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=8750-7587&client=summon |